M&A Trends: PE Take Privates on the Rise

Key Takeaways

• PE take‑privates rose 9% month‑over‑month.
• Deal value jumped 139% despite 15% volume decline.
• $100m+ deals up 224% in value, down 9% volume.
• $1bn+ transactions surged 319% value, 38% volume.
• Sponsors seek operational upgrades and growth repositioning.

Summary

EY Parthenon’s February 2026 report shows private‑equity‑backed take‑private deals rising 9% month‑over‑month, while overall M&A deal value jumped 139% as transaction volume fell 15%. Large‑scale deals are driving the surge: transactions of $100 million + grew 224% in value and $1 billion + deals surged 319% in value and 38% in volume. Sponsors are targeting public companies with strong assets but strategic constraints, aiming to accelerate operational improvements and reposition businesses toward higher‑growth opportunities. The trend underscores growing confidence in private ownership to capture multiyear value creation.

Pulse Analysis

The February 2026 EY Parthenon report signals a decisive pivot toward private‑equity‑driven take‑private transactions. After a modest 9% month‑over‑month rise, sponsors are targeting public companies that possess solid asset bases but are hamstrung by the quarterly reporting cadence, activist pressure, and regulatory scrutiny that limit long‑term strategic execution. By moving these firms into private hands, investors can bypass public‑market volatility, implement cost‑cutting programs, and re‑engineer business models toward higher‑margin or faster‑growing segments. This approach reflects a broader belief that private governance structures unlock value that public shareholders often cannot realize.

The data also reveals a pronounced skew toward mega‑deals. Transactions valued at $100 million or more surged 224% in dollar terms, while billion‑dollar deals exploded 319% and grew 38% in count. Such concentration amplifies the importance of deep‑pocketed funds and syndication networks, pressuring banks and advisory firms to prioritize large‑scale financing solutions. For institutional investors, the shift means exposure to fewer, but larger, private‑equity commitments, potentially raising portfolio concentration risk. Meanwhile, public‑market participants may experience reduced liquidity in mid‑cap segments as capital gravitates toward these headline‑making buyouts.

Looking ahead, the momentum behind take‑privates is likely to persist as long as public‑market constraints remain and private equity continues to amass dry powder. Companies with strong cash flows yet limited strategic flexibility are prime candidates for privatization, especially in sectors such as technology, healthcare, and industrials where rapid innovation cycles demand swift decision‑making. However, heightened competition for large assets could inflate purchase premiums and compress returns, prompting sponsors to sharpen operational playbooks and seek synergistic add‑on acquisitions. Stakeholders should monitor regulatory sentiment, as antitrust scrutiny on mega‑transactions may introduce new hurdles to this evolving M&A paradigm.